The cholesterol-lowering therapy evolocumab reduced the risk of serious adverse cardiac events by nearly one-third in patients with diabetes and no known significant atherosclerosis, according to...
A new study presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology (ACAAI) provides encouraging news for parents of...
New findings from the landmark SELECT trial reveal that semaglutide's cardiovascular benefits are only partially explained by reduced waist size, suggesting broader protective effects beyond fat...
The review of the Lancet shows a modest yet meaningful slowdown between lekanemab and donanemab, highlighting the plasma P-TAU217 as a scalable triage marker. Although ARIA...
Systematic reviews reveal apple cider vinegar as a promising and accessible aid to body weight and metabolic health, but larger long-term studies are needed to confirm...
Walking the dog for a while became dangerous. Earl Vickers was used to bringing Molly, a mix of his shepherd boxer Somer Els Els, to walk...
Recent Comments